pubmed-article:12944913 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0085296 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0085828 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0162508 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0205145 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0205107 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0040715 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C1171362 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C1522702 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0162768 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0439852 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0599718 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0599813 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0599893 | lld:lifeskim |
pubmed-article:12944913 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:12944913 | pubmed:issue | 36 | lld:pubmed |
pubmed-article:12944913 | pubmed:dateCreated | 2003-8-28 | lld:pubmed |
pubmed-article:12944913 | pubmed:abstractText | Overexpression of proto-oncogene c-jun and constitutive activation of the Jun N-terminal kinase (JNK) signaling pathway have been implicated in the leukemic transformation process. However, c-jun expression and the role of the JNK signaling pathway have not been investigated in primary acute myeloid leukemia (AML) cells with frequently observed balanced rearrangements such as t(8;21). In the present study, we report elevated c-jun mRNA expression in AML patient bone marrow cells with t(8;21), t(15;17) or inv(16), and a high correlation in mRNA expression levels of AML1-ETO and c-jun within t(8;21)-positive AML patient cells. In myeloid U937 cells, c-jun mRNA and protein expression increase upon inducible expression of AML1-ETO. AML1-ETO transactivates the human c-jun promoter through the proximal activator protein (AP-1) site by activating the JNK pathway. Overexpression of JNK-inhibitor JIP-1 and chemical JNK inhibitors reduce the transactivation capacity of AML1-ETO on the c-jun promoter and the proapoptotic function of AML1-ETO in U937 cells. An autocrine mechanism involving granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor (G-CSF-R) might participate in AML1-ETO mediated JNK-signaling, because AML1-ETO induces G-CSF and G-CSF-R expression, and G-CSF-R-neutralizing antibodies reduce AML1-ETO-induced JNK phosphorylation. These data suggest a model in which AML1-ETO induces proto-oncogene c-jun expression via the proximal AP-1 site of the c-jun promoter in a JNK-dependent manner. | lld:pubmed |
pubmed-article:12944913 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:language | eng | lld:pubmed |
pubmed-article:12944913 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12944913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12944913 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12944913 | pubmed:month | Aug | lld:pubmed |
pubmed-article:12944913 | pubmed:issn | 0950-9232 | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:ZhangDong-ErD... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:SchnittgerSus... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:SchochClaudia... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:TenenDaniel... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:HiddemannWolf... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:BehreGerhardG | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:ReddyVenkates... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:KohlmannAlexa... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:FranzenMichae... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:UeffingMarius... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:ElsässerAnnik... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:WeisserMartin... | lld:pubmed |
pubmed-article:12944913 | pubmed:author | pubmed-author:BurelSebastia... | lld:pubmed |
pubmed-article:12944913 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12944913 | pubmed:day | 28 | lld:pubmed |
pubmed-article:12944913 | pubmed:volume | 22 | lld:pubmed |
pubmed-article:12944913 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12944913 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12944913 | pubmed:pagination | 5646-57 | lld:pubmed |
pubmed-article:12944913 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:meshHeading | pubmed-meshheading:12944913... | lld:pubmed |
pubmed-article:12944913 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12944913 | pubmed:articleTitle | The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner. | lld:pubmed |
pubmed-article:12944913 | pubmed:affiliation | Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-University Munich, Germany. | lld:pubmed |
pubmed-article:12944913 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12944913 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:12944913 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12944913 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12944913 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12944913 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12944913 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12944913 | lld:pubmed |